Related references
Note: Only part of the references are listed.Multiple comparisons: a tutorial. Part 1. Understanding hypothesis testing
Michael T. Lawson et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2021)
Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy
Eric J. Velazquez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: Anemia, Biomarkers, and Recent Therapeutic Trial Implications
Gordon W. Moe et al.
CANADIAN JOURNAL OF CARDIOLOGY (2015)
Making Sense of Statistics in Clinical Trial Reports Part 1 of a 4-Part Series on Statistics for Clinical Trials
Stuart J. Pocock et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
The statistical significance of randomized controlled trial results is frequently fragile: a case for a Fragility Index
Michael Walsh et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2014)
The large-scale placebo-controlled beta-blocker studies in systolic heart failure revisited: results from CIBIS-II, COPERNICUS and SENIORS-SHF compared with stratified subsets from MERIT-HF
J. Wikstrand et al.
JOURNAL OF INTERNAL MEDICINE (2014)
Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial
Gerhard Hindricks et al.
LANCET (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Clyde W. Yancy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure
Karl Swedberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Cardiac-Resynchronization Therapy in Heart Failure with a Narrow QRS Complex
Frank Ruschitzka et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Effect of Amlodipine on the Survival of Patients With Severe Chronic Heart Failure Due to a Nonischemic Cardiomyopathy Results of the PRAISE-2 Study (Prospective Randomized Amlodipine Survival Evaluation 2)
Milton Packer et al.
JACC-HEART FAILURE (2013)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
John J. V. McMurray et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2012)
Does cardiac insufficiency receive AVK?
Helene Vaillant-Roussel et al.
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2012)
Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review
Elie A. Akl et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
John J. V. McMurray et al.
EUROPEAN HEART JOURNAL (2012)
Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm
Shunichi Homma et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial
William T. Abraham et al.
LANCET (2011)
Coronary-Artery Bypass Surgery in Patients with Left Ventricular Dysfunction
Eric J. Velazquez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Number of Patients and Events Required to Limit the Risk of Overestimation of Intervention Effects in Meta-Analysis-A Simulation Study
Kristian Thorlund et al.
PLOS ONE (2011)
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Karl Swedberg et al.
LANCET (2010)
Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure.
Anthony S. L. Tang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Impact of Implantable Cardioverter-Defibrillator, Amiodarone, and Placebo on the Mode of Death in Stable Patients With Heart Failure Analysis From the Sudden Cardiac Death in Heart Failure Trial
Douglas L. Packer et al.
CIRCULATION (2009)
Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials
Marco Metra et al.
EUROPEAN HEART JOURNAL (2009)
Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure HF-ACTION Randomized Controlled Trial
Christopher M. O'Connor et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial
Marvin A. Konstam et al.
LANCET (2009)
Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device
Mark S. Slaughter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events.
Arthur J. Moss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A randomised trial of a pre-synaptic stimulator of DA(2)-dopaminergic and alpha(2)-adrenergic receptors on morbidity and mortality in patients with heart failure
Christian Torp-Pedersen et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Results of a non-specific immunomodulation therapy on chronic heart failure (ACCLAIM trial):: a placebo-controlled randomised trial
Guillermo Torre-Amione et al.
LANCET (2008)
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Luigi Tavazzi et al.
LANCET (2008)
Increased mortality after dronedarone therapy for severe heart failure
Lars Kober et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Rhythm control versus rate control for atrial fibrillation and heart failure
Denis Roy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Rosuvastatin in older patients with systolic heart failure
John Kjekshus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The effect of cardiac resynchronization on morbidity and mortality in heart failure
JGF Cleland et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure - COMET
C Torp-Pedersen et al.
AMERICAN HEART JOURNAL (2005)
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure
GH Bardy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Combination of isosorbide dinitrate and hydralazine in blacks with heart failure
AL Taylor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
MR Bristow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors:: the CHARM-Alternative trial
CB Granger et al.
LANCET (2003)
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors:: the CHARM-Added trial
JJV McMurray et al.
LANCET (2003)
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol, European Trial (COMET): randomised controlled trial
PA Poole-Wilson et al.
LANCET (2003)
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
B Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Effect of carvedilol on the morbidity of patients with severe chronic heart failure - Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study
M Packer et al.
CIRCULATION (2002)
Comparison of omapatrilat chronic and enalapril in patients with heart failure - The omapatrilat versus enalapril randomized trial of utility in reducing events (OVERTURE)
M Packer et al.
CIRCULATION (2002)
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
JN Cohn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Long-term use of a left ventricular assist device for end-stage heart failure
EA Rose et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Cardiovascular critical event pathways for the progression of heart failure -: A report from the ATLAS study
JGF Cleland et al.
EUROPEAN HEART JOURNAL (2001)
Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure -: The metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF)
Å Hjalmarson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Effect of mibefradil, a T-type calcium channel blocker, on morbidity and mortality in moderate to severe congestive heart failure - The MACH-1 study
TB Levine et al.
CIRCULATION (2000)
Share Paper
